Immediate Impact
1 from Science/Nature 53 standout
Citing Papers
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
The biofilm life cycle: expanding the conceptual model of biofilm formation
2022 Standout
Works of Charles Kromann being referenced
Hidradenitis suppurativa in a cohort of overweight and obese children and adolescents
2019
Risk factors, clinical course and long‐term prognosis in hidradenitis suppurativa: a cross‐sectional study
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Charles Kromann | 146 | 284 | 93 | 295 | 176 | 22 | 750 | |
| Brian V Reamy | 63 | 327 | 57 | 113 | 202 | 42 | 970 | |
| Bryan Martin | 129 | 55 | 18 | 116 | 125 | 34 | 656 | |
| Mike Davis | 133 | 80 | 9 | 63 | 55 | 33 | 682 | |
| Phoebe Lindsey Barton | 92 | 82 | 16 | 47 | 278 | 17 | 979 | |
| Kim O’Connor | 105 | 236 | 29 | 40 | 325 | 26 | 960 | |
| Sue E. Huether | 53 | 176 | 5 | 177 | 44 | 19 | 664 | |
| Corinne H. Miller | 50 | 147 | 6 | 77 | 145 | 41 | 660 | |
| Patrick Quinn | 162 | 187 | 29 | 60 | 129 | 49 | 703 | |
| Suzanne Dooley‐Hash | 160 | 221 | 43 | 9 | 250 | 28 | 888 | |
| Erdoǵan Günel | 20 | 34 | 12 | 118 | 70 | 42 | 932 |
All Works
Login with ORCID to disown or claim papers
Loading papers...